Seattle Cancer Care Alliance (SCCA) leaders responded to the COVID-19 outbreak with unprecedented speed, thoughtful consideration and collaboration. Rapidly established COVID-19 infection prevention protocols allowed our staff to provide compassionate care while protecting our patients from the pandemic. At the forefront of our response, Dr. Steve Pergam, Medical Director of Infection Prevention and Dr.
Throughout this unprecedented global crisis, Seattle Cancer Care Alliance (SCCA) has developed and enacted new protocols to ensure safety for our patients, staff, and community. As Washington State successfully flattened the COVID-19 curve, we’ve re-opened services that were deferred amid the outbreak. “We’re proud of the continued excellent care our oncologists and care teams are providing patients during the COVID-19 pandemic,” stated Renato Martins, MD, MPH, Medical Director for SCCA’s Thoracic Team, in his role as Ambulatory Medical Chief of SCCA’s COVID-19 response team.
Our commitment to safety, innovation, and caring for the most vulnerable is at the forefront of our COVID response. Our blood and marrow transplant (BMT), cellular immunotherapy (IMTX) and Hematology & Heme Malignancy (HHM) programs have decades of experience developing infection prevention and safety protocols, allowing our teams to safely continue care for those seeking novel blood disorder treatments amid COVID-19.
The Seattle Cancer Care Alliance (SCCA) provider education team provides digital opportunities to learn, connect, and share. As we expand our online learning opportunities, let us know how we can best support your needs. The survey below will take a minimum of 60 seconds, and will help ensure we share relevant, practice changing information with you in an actionable way. Taking this survey will allow our team to share customized digital education with you.
At Seattle Cancer Care Alliance (SCCA), we’re ensuring that patients get the care and support they need, while taking steps to keep them, their loved ones and our staff as safe and healthy as possible during the COVID-19 pandemic. Most SCCA services are open and operating normally. Here’s an update on our current operations:
Nancy Davidson, MD, and President of Seattle Cancer Care Alliance (SCCA) shares key learnings from the epicenter of the initial outbreak of COVID-19 in the United States. Recorded April 7, 2020
At Seattle Cancer Care Alliance (SCCA), the health and safety of patients, caregivers and staff is our number one priority. That’s why we quickly developed processes and protocols that allow us to continue many vital services — including in-person care for patients with urgent medical needs — during the COVID-19 outbreak, while minimizing the risk of exposure to all patients, their loved ones and our team.
Patients undergoing blood and marrow transplants are especially vulnerable to COVID-19, and Seattle Cancer Care Alliance (SCCA) is doing everything we can to keep them as safe and healthy as possible. The Fred Hutch / SCCA Blood and Marrow Transplant Program have implemented a variety of protocols to protect these patients and remain operational, and our Intake Office is here to discuss clinical cases with you.
The Bezos Family Immunotherapy Clinic at SCCA quickly enacted protocols to protect patients receiving cellular immunotherapy treatment amid COVID-19 and is operational for your patients who may benefit from cellular therapy. Our immunotherapy intake coordinators (PA-C, ARNP) can be reached to coordinate eligibility and suitability for immunotherapy treatment options, including commercial CAR T-cell treatments and clinical trial options.